Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6189735 | Brachytherapy | 2013 | 9 Pages |
Abstract
As brachytherapy TPSs implement advanced model-based dose calculations, the analytic applicator models stored in TPSs should be independently validated before clinical use. For this cohort, clinically meaningful differences (>5%) from TG-43 were observed. Accurate dosimetric modeling of shielded applicators may help to refine organ toxicity studies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Justin K. Mikell, Ann H. Klopp, Michael Price, Firas Mourtada,